Narasimha Boorgu, MD
Nephrology · Florence, ALNPI 1043218928
Payments from drug & device makers
Across 574 payments — averaging $16.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vifor Pharma, Inc.$1K
- OPKO Pharmaceuticals, LLC$1K
- Amgen$914
- Otsuka America Pharmaceutical, Inc.$754
- AstraZeneca$708
- Akebia Therapeutics Inc$703
- plus $4K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vifor Pharma, Inc. | 76 | $1,120 |
| OPKO Pharmaceuticals, LLC | 112 | $1,045 |
| Amgen(2 entities) | 54 | $914 |
| Otsuka America Pharmaceutical, Inc. | 42 | $754 |
| AstraZeneca(2 entities) | 38 | $708 |
| Akebia Therapeutics Inc | 35 | $703 |
| Bayer | 28 | $540 |
| Calliditas Therapeutics US Inc. | 21 | $447 |
| Novartis | 15 | $392 |
| Novo Nordisk | 23 | $382 |
| Boehringer Ingelheim | 16 | $322 |
| Lilly USA, LLC | 16 | $289 |
| GSK | 14 | $246 |
| Mallinckrodt Hospital Products Inc. | 10 | $231 |
| Sanofi-aventis U.S. LLC | 12 | $178 |
| Mallinckrodt Enterprises LLC | 6 | $169 |
| Fresenius USA Marketing, Inc. | 8 | $158 |
| Ardelyx, Inc. | 9 | $151 |
| Corcept Therapeutics | 6 | $124 |
| Travere Therapeutics, Inc. | 5 | $118 |
| Aurinia Pharma U.S., Inc. | 4 | $105 |
| Abbott | 4 | $73 |
| Bard Peripheral Vascular, Inc. | 2 | $56 |
| Shield Therapeutics Inc | 2 | $41 |
| Shire North American Group Inc | 3 | $40 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Insulet Corporation | 1 | $30 |
| Ascendis Pharma Endocrinology Inc | 1 | $28 |
| Vantive US Healthcare LLC | 1 | $25 |
| BETA Bionics, Inc. | 1 | $24 |
| Nuwellis, Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Apellis Pharmaceuticals, Inc. | 1 | $15 |
| Medtronic | 1 | $12 |
How this compares
$9,574 in reported general payments places this provider in the 75th percentile of 164 nephrology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Florence
- Subir PaulFlorence$57K
- David TietjenHuntsville$2.6M
- Dana RizkBirmingham$2.6M
- Michael QuadriniHuntsville$1.3M
- Eric WallaceBirmingham$1.3M
- David BainsHuntsville$856K
- Michal MrugBirmingham$793K
- Phillip MadoniaAlabaster$475K
- Carlo CastilloHuntsville$461K
- Sumeet MunjalMontgomery$191K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.